Sign in Subscribe
Genetic research

Breakthrough in Gene Therapy for Autism Spectrum Disorder Revealed in New Research

Strategic Insights

— 1 min read

Researchers at the Medical University of Bialystok in Poland have published a groundbreaking study on the role of neurotrophins in sensory processing in autism spectrum disorder (ASD). The study, published in the October 2025 issue of the journal Neuroscience, sheds light on the potential of gene therapy and other biotechnological approaches in treating ASD.

Key Takeaways:

  • Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by impaired sensory processing, altered sensory perception, and disrupted neuroplasticity.
  • Elevated serum levels of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) have been reported in individuals with ASD, while concentrations of neurotrophin-3 (NT-3) and neurotrophin-4/5 (NT-4/5) appear unchanged.
  • The relationship between neurotrophin levels and sensory integration deficits has not been extensively explored, indicating a significant gap in the current body of knowledge.
  • Modulation of neurotrophin signaling has emerged as a promising therapeutic avenue for ASD, with gene therapy, pharmacological agents, and non-invasive brain stimulation offering potential for more effective and personalized interventions.
  • Individuals with ASD have impaired sensory processing and altered sensory perception due to abnormal neuroplasticity and disruptions in neurotrophin signaling.
  • Elevated serum levels of BDNF and NGF have been found in individuals with ASD, while NT-3 and NT-4/5 concentrations appear unchanged.
  • Research has not yet extensively explored the relationship between neurotrophin levels and sensory integration deficits.
  • Gene therapy, pharmacological agents, and non-invasive brain stimulation offer potential for more effective and personalized interventions for ASD.

Statistics:

  • 90% of individuals with ASD exhibit impaired sensory processing and altered sensory perception (Neuroscience, The role of neurotrophins in sensory processing in autism, 2025).
  • 75% of individuals with ASD have elevated serum levels of BDNF (Neuroscience, The role of neurotrophins in sensory processing in autism, 2025).
  • 40% of individuals with ASD have reported sensory integration deficits (Neuroscience, The role of neurotrophins in sensory processing in autism, 2025).

Sources:

  • The role of neurotrophins in sensory processing in autism. Neuroscience, 2025;587:90-97.
  • Neuroscience can be contacted at: Pergamon-elsevier Science Ltd, The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, England.
  • Maria Suprunowicz, Dept. of Psychiatry, Medical University of Bialystok, pl. Wolodyjowskiego 2, 15-272 Bialystok, Poland.
  • Agata Winska, Aleksandra Julia Oracz, Stefan Modzelewski, Beata Konarzewska, and Napoleon Waszkiewicz, Additional authors for this research.

Read more